Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression.

ABSTRACT:

Objective

Schizophrenia has been associated with patients' poor quality of life, disability, and hospitalization. As of today, evidence that highlights the association between schizophrenia and coronavirus disease (Covid-19) outcomes remains unclear. This study sought to analyze whether patients with pre-existing schizophrenia are at higher risk for Covid-19 mortality.

Methods

Using specific keywords, we comprehensively searched PubMed, Scopus, OVID, and Cochrane Library sources until November 15th, 2021. All published studies on schizophrenia and Covid-19 were collected. We used Review Manager 5.4 and Comprehensive Meta-Analysis 3 software to conduct statistical analysis.

Results

There were 10 studies with 263,207 Covid-19 patients included in the analysis. Evaluatio

SUBMITTER: Pardamean E 

PROVIDER: S-EPMC8813760 | biostudies-literature | 2022 Mar-Apr

REPOSITORIES: biostudies-literature